NADIA MCFARLANE: Open Payments
NPI 1619175239 · KATY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$18,428 in 47 payments from 17 companies in 2025. Trend: 2023 $616 · 2024 $409 · 2025 $18,428
Debt forgiveness: $17,410Food & beverage: $1,018
| Company | Payments | Amount |
|---|---|---|
| Neuronetics, Inc. | 1 | $17,410 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $177 |
| Axsome Therapeutics, Inc. | 4 | $108 |
| Corium, LLC | 4 | $105 |
| E.R. Squibb & Sons, L.L.C. | 5 | $101 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $100 |
| Collegium Pharmaceutical, Inc. | 4 | $85 |
| Otsuka America Pharmaceutical, Inc. | 2 | $59 |
| Supernus Pharmaceuticals, Inc. | 3 | $49 |
| Tris Pharma Inc | 2 | $44 |
Products named: NEUROSTAR TMS THERAPY SYSTEM, TRINTELLIX, Auvelity, Azstarys, COBENFY, CAPLYTA, Jornay PM, REXULTI.
Industry payments across TX — which companies pay providers there.
